Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Instituto Nacional de Salud Pública
2015
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=10636867009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Primary drug resistance in a region with high burden of tuberculosis. A critical problem Cecilia Villa-Rosas Rafael Laniado-Laborín Lorena Oceguera-Palao Salud Rosas isoniazid rifampin Villa Treatment outcome resistance amplification Objective. To determine rates of drug resistance in new cases of pulmonary tuberculosis in a region with a high burden of the disease. Materials and methods. New case suspects were referred for drug susceptibility testing. Results. 28.9% of new cases were resistant to at least one first line drug; 3.9% had a multidrug-resistant strain, 15.6% a monoresistant strain and 9.4% a polyresistant strain. Conclusion. Our rate of drug resistant tuberculosis in new cases is very high; this has important clinical implications, since even monoresistance can have a negative impact on the outcome of new cases treated empirically with a six month regimen. C, Laniado-Laborín R, Oceguera-Palao L. Farmacorresistencia en casos nuevos en una región con alta carga de tuberculosis. Un problema crítico. Salud Publica Mex 2015;57:177-179. 2015 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10636867009 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.2 Vol.57